TCL Archive Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40. May 1, 2009
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality. February 29, 2008
TCL Archive Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s January 17, 1992
